Nicholas Hollmeyer Lynton - Apr 20, 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Signature
/s/ Nick Lynton
Stock symbol
CDLX
Transactions as of
Apr 20, 2025
Transactions value $
-$458
Form type
4
Date filed
4/22/2025, 08:27 PM
Previous filing
Apr 3, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +682 +0.67% 102K Apr 20, 2025 Direct F1
transaction CDLX Common Stock Sale -$458 -303 -0.3% $1.51 102K Apr 22, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -682 -100% $0.00 0 Apr 20, 2025 Common Stock 682 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2 Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 20, 2025. The Reporting Person did not sell shares for any other purpose.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.485 to $1.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 This RSU award was originally for 2,727 shares. 25% of the shares underlying the RSU award vested on each of April 20, 2022, April 20, 2023, April 20, 2024, and April 20, 2025.